|
[1]
|
Virani, S.S., Newby, L.K., Arnold, S.V., Bittner, V., Brewer, L.C., Demeter, S.H., et al. (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 148, e9-e11. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Einarson, T.R., Acs, A., Ludwig, C. and Panton, U.H. (2018) Prevalence of Cardiovascular Disease in Type 2 Diabetes: A Systematic Literature Review of Scientific Evidence from across the World in 2007-2017. Cardiovascular Diabetology, 17, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Bornfeldt, K.E. and Tabas, I. (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism, 14, 575-585. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R.A., Antunes, M.J., et al. (2023) 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. European Heart Journal, 44, 4043-4140. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lawton, J.S., Tamis-Holland, J.E., Bangalore, S., Bates, E.R., Beckie, T.M., Bischoff, J.M., et al. (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e4-e17. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kronenberg, F., Mora, S., Stroes, E.S.G., Ference, B.A., Arsenault, B.J., Berglund, L., et al. (2022) Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement. European Heart Journal, 43, 3925-3946. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Berman, A.N., Biery, D.W., Besser, S.A., Singh, A., Shiyovich, A., Weber, B.N., et al. (2024) Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients with or without Baseline Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology, 83, 873-886. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
da Silva, A., Caldas, A.P.S., Hermsdorff, H.H.M., Bersch-Ferreira, Â.C., Torreglosa, C.R., Weber, B., et al. (2019) Triglyceride-Glucose Index Is Associated with Symptomatic Coronary Artery Disease in Patients in Secondary Care. Cardiovascular Diabetology, 18, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Luo, T., Chen, S., Cai, J., Liu, Q., Gou, R., Mo, X., et al. (2022) Association between Combined Exposure to Plasma Heavy Metals and Dyslipidemia in a Chinese Population. Lipids in Health and Disease, 21, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
ElSayed, N.A., McCoy, R.G., Aleppo, G., Balapattabi, K., Beverly, E.A., Briggs Early, K., et al. (2024) 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care, 48, S27-S49. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Fihn, S.D., Gardin, J.M., Abrams, J., Berra, K., Blankenship, J.C., Dallas, A.P., et al. (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation, 126, e354-e471. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Crengle, S. (2020) Comment On: Jaine Et Al Cost-Effectiveness of a Low-Dose Computed Tomography Screening Programme for Lung Cancer in New Zealand. Lung Cancer 2018, 124, 233-240. 2018/10/01. Lung Cancer, 145, 219-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Jiang, Z., Ruan, S., Duan, Q., Zhang, W. and Pan, S. (2025) Predictive Value of Lp(a) for MACE in ACS Patients with T2DM Following PCI, with Achieved LDL-C Target: A Cross-Sectional Study. Science Progress, 108, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Xu, S., Qin, Z., Yuan, R., Cui, X., Zhang, L., Bai, J., et al. (2022) The Hemoglobin Glycation Index Predicts the Risk of Adverse Cardiovascular Events in Coronary Heart Disease Patients with Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine, 9, Article 992252. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhong, M., Tian, X., Sun, Q., Li, L., Lu, Y., Feng, Z., et al. (2023) Correlation of Asprosin and NRG-4 with Type 2 Diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value. BMC Endocrine Disorders, 23, Articek No. 61. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Nurmohamed, N.S., Moriarty, P.M. and Stroes, E.S. (2022) Considerations for Routinely Testing for High Lipoprotein(a). Current Opinion in Lipidology, 34, 174-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sagris, M., Antonopoulos, A.S., Theofilis, P., Oikonomou, E., Siasos, G., Tsalamandris, S., et al. (2021) Risk Factors Profile of Young and Older Patients with Myocardial Infarction. Cardiovascular Research, 118, 2281-2292. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Bittner, V.A., Szarek, M., Aylward, P.E., Bhatt, D.L., Diaz, R., Edelberg, J.M., et al. (2020) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk after Acute Coronary Syndrome. Journal of the American College of Cardiology, 75, 133-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zeng, J., Li, N., Ma, C., Song, Y., Tian, W., Gao, Y., et al. (2025) Association between Triglyceride-Glucose Index and Postoperative Delirium Following Cardiac Surgery: A Multicenter Retrospective Analysis. Lipids in Health and Disease, 24, Article No. 330. [Google Scholar] [CrossRef]
|
|
[21]
|
Bulut, M., Celik, F.B., Guvenc, T.S., Yilmaz, Y., Celik, M., Ozyildirim, S., et al. (2024) Usefulness of Triglyceride-Glucose Index and Homeostatic Model Assessment for Predicting Coronary Microvascular Dysfunction. Journal of Clinical Lipidology, 18, e764-e772. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Tai, S., Fu, L., Zhang, N., Zhou, Y., Xing, Z. and Wang, Y. (2022) Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article 858209. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Vergès, B. (2015) Pathophysiology of Diabetic Dyslipidaemia: Where Are We? Diabetologia, 58, 886-899. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Reyes-Soffer, G., Ginsberg, H.N., Berglund, L., Duell, P.B., Heffron, S.P., Kamstrup, P.R., et al. (2022) Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 42, e48-e60. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
van der Valk, F.M., Bekkering, S., Kroon, J., Yeang, C., Van den Bossche, J., van Buul, J.D., et al. (2016) Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. Circulation, 134, 611-624. [Google Scholar] [CrossRef] [PubMed]
|